Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Poolbeg Pharma Ltd. ( (GB:POLB) ) is now available.
Poolbeg Pharma has announced the release of its Annual Report and Accounts for the period ending December 31, 2024, along with the notice for its Annual General Meeting (AGM) scheduled for June 23, 2025. The company has also issued a Circular detailing a fundraising initiative, which will be sent to shareholders. These documents are available on the company’s website. This announcement underscores Poolbeg Pharma’s ongoing efforts to engage shareholders and secure funding, which could impact its operational capabilities and market position.
More about Poolbeg Pharma Ltd.
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focused on developing innovative medicines to address unmet medical needs. The company’s clinical programs target large addressable markets, including cancer immunotherapy-induced Cytokine Release Syndrome (CRS) and metabolic conditions such as obesity, with the development of an oral encapsulated glucagon-like peptide GLP-1R agonist.
Average Trading Volume: 1,003,463
Technical Sentiment Signal: Sell
For detailed information about POLB stock, go to TipRanks’ Stock Analysis page.